Presentations
1. Chemoprevention in mice by 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids. M.R. Franklin, J.C. Roberts, W.M. El-Sayed, T. Aboul-Fadl, T. Schofield, J.E. Constance and J.G. Lamb. The 46th Annual Meeting (SOT), Charlotte, NC-USA, March 2007. Abstract 609, Toxicological Sciences p126S.
2. Design, Synthesis and Antitubercular Evaluation of Small Schiff Base Combinatorial Library. Wesam S. Abd-el Aal, Hoda Y. Hassan, Tarek Aboul-Fadl , Adel F. Youssef. The 7th International Saudi Pharmaceutical Conference. Riyadh-Saudi Arabia, March 19-21 2007.
3. Effects of acute exposure of selenazolidines prodrugs of L-selenocysteine on chemoprotective enzymes in mice and Hepa1c1c7 cells. Wael M. El-Sayed, Tarek Aboul-Fadl, John G. Lamb, Jeanette C. Roberts and Michael R. Franklin. The 45th Annual Meeting of the Society of Toxicology (SOT), San Diego, California-USA, March 5-9, 2006.
4. The biological effects of selenocysteine prodrugs. Wael M. El-Sayed, Tarek Aboul-Fadl, John G. Lamb, Jeanette C. Roberts and Michael R. Franklin, Annual Bioscience Symposium, University of Utah, Salt Lake City, Utah-USA, September 9, 2005.
5. Uptake of L-Selenaproline by the L-Cystine Transport System in Escherichia coli, C. E. Deutch, M. E. Arballo, L. N. Cooks, J. M. Gomes, T. M. Williams, T. Aboul-Fadl, and J. C. Roberts. 105th General Meeting of the American Society for Microbiology, Atlanta, Georgia, USA, June 5-9, 2005.
6. Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents, Tarek Aboul-Fadl, Wael M. El-Sayed, Tenley Schofield, Jonathan Constance, John G. Lamb, Jeanette C. Roberts, and Michael R. Franklin. 229th ACS National Meeting, San Diego, California, USA, March 13-17, 2005.
7. Phase II Drug Metabolizing Enzyme mRNA Changes by Novel Selenazolidine Prodrugs of Selenocysteine in Mice, Wael M. El-Sayed, Tarek Aboul-Fadl, Ronald B. McEwen, Tenley Schofield, John G. Lamb, Jeanette C. Roberts and Michael R. Franklin, The 22nd Annual Meeting of the Mountain West Society of Toxicology (MWSOT), Park City – Utah, USA. September 9-10, 2004. P.18
8. Synthesis of 5-Phenyl-1-(Pyridyl)-1H-1,2,4-triazole-3-Carboxylic Acid Derivatives of potential Antiinflammatory Activity, Safwat M. Rabea,Tarek Aboul-Fadl, Nawal A. El-Koussi and Hoda Y. Hassan, Assiut University 4th Pharmaceutical Sciences Conference, Assiut - Egypt. March 6-7, 2004. P.122.
9. Synthesis and Antitubercular Activity of some Schiff Bases Derived from Mannich Bases of Isatin and Isonicotinic Acid Hydrazide (INH), Mostafa Hussein, Tarek Aboul-Fadl and Asmaa Abdel-Nasser, Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, KrakÓw, Poland 15-18 October 2003.
10. Unusual “Senseless” 2’-5’ Oligoribonucleotide with a Potent Anti-HIV Activity, Tarek Aboul-Fadl, Vijai Agrawal, Robert W. Buckheit Jr and Arthur D. Broom, The 1st International Congress of Pharmaceutical and Drug Industries Division, National Research Center, Cairo-Egypt, March 24-26(2003).p.118
11. Synthesis of a Peptide Nucleic Acid with a Novel 1-Methyl-6-thiopurine Base, Tarek Aboul-Fadl, K.G. Rajeev and A.D. Broom, 223 ACS meeting, Orlando, Florida-USA, April 6-11 (2002).
12. 1,2-Dihydroisoquinoline Derivatives as New Carrier for Brain Specific Delivery, Sahar M. Mohamoud, Mahmoud M. Sheha, Tarek Aboul-Fadl and Hassan H. Farag, Assiut University Third Pharmaceutical Sciences Conference, Assiut-Egypt, March 5-6 (2002).
13. Synthsis of New Optically Active Thiadiazine-2-thione Derivatives as Antifungal Agents, M.A. Hussein and T. Aboul-Fadl, 8th IBN SINA Intrnational Conference on Pure and Apllied Heterocyclic Chemistry, Luxor-Egypt, Feb. 16-19 (2002).
14. Synthesis and Antifungal Activity of Some New 3,5-Disubstiuted Tetrahydro-2H-1,3,5-Thiadiazine-2-Thione, T. Aboul-Fadl, M.A. Hussein and A. A. El-Shorbagi, XXVII Conference of Egyptian Pharmaceutical Society, Cairo - Egypt, January 2-4 (2001), P.57.
15. Synthesis of 7-Substituted 3-[4(4-Chlorophenyl)-Piperazin-1-ylmethyl]-Pyrazolo[1,5-a]Pyridine Derivatives as Potential D4-Receptor Ligands, T. Aboul-Fadl, S. Löber and P. Gmeiner, XXVII Conference of Egyptian Pharmaceutical Society, Cairo - Egypt, January 2-4(2001), P. 56.
16. Chitosan Conjugates of Ibuprofen and Flurbiprofen: Synthesis, Characterization and in vitro Stability, T. Aboul-Fadl, M. M. Sheha and S. Khider, XXVI Conference of Egyptian Pharmaceutical Society, Cairo- Egypt, December 8-10(1998), p. 31.
17. Flow injection analysis of amino acids using Cu(II) oxide as a packed reactor for ultraviolet detection, S. Emara and T. Aboul-Fadl, Fourth European Congress of Pharmaceutical Sciences, Milan-Italy, September 11-13(1998).
18. Cyclic amide derivatives as potential prodrugs: N-hydroxmethyl-succinimide-/isatin esters of some NSAIDs as chemical delivery system with improved therapeutic index, F. A. Omar, N. M. Mahfouz and T. Aboul-Fadl, XIV Scientific Meeting of the Austrian Pharmaceutical Society, Graz - Austria, June 11-13(1998), p. S85.
19. A Structurally Simplified Analogue of the Antibiotic Heptelidic Acid With a Five Membered Carbocyclic Ring, T. Aboul-Fadl, W. Fleischhacker and E. Urban, XIV Scientific Meeting of the Austrian Pharmaceutical Society, Graz -Austria, June 11-13(1998), p. S15.
20. Acetaminophen Esters of Some Non-steroidal Antiinflammatory Drugs as Mutual Prodrugs with Improved Therapeutic Index, T. A. Fadl and F. A. Omar, Assiut University First International Pharmaceutical Sciences Conference, Faculty of Pharmacy, Assiut-Egypt, March 4-5(1998), p. 3.
21.Metronidazle Twin Esters Prodrugs II : Non Identical Twin Esters of Metronidazole and Some Antiprotozoal Halogenated Hydroxyquinoline Derivatives, T. Aboul-Fadl, N. M. Mahfouz and A. K. Diab, Assiut University First International Pharmaceutical Sciences Conference, Faculty of Pharmacy, Assiut-Egypt, March 4-5(1998), p. 1.
22. Modifications of Paeoniflorin and Paeonimetabolin I by Chemical and Biochemical Means, Abdel-Hafez, M. R. Meselhy, N. Nakamura, M. Hattori, H. Watanabe, T. A. Mohamed, N. M. Mahfouz and M. A. El-Gendy, International Symposium on Natural Medicines, Kyoto - Japan, October 28 -30(1997), p. 3P-032.
23. Tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives as new carriers for peptide drugs, T. Aboul-Fadl and A. El-Shorbagi, XXV Conference of Egyptian Pharmaceutical Society, Cairo- Egypt, December 24-26(1996), p. 68.
24. Synthesis and Investigation of the Alkylating Potential of 2-(3-Arylpropen-oyl)benzimidazole and their Corresponding N1-methyl Derivatives, T. Aboul-Fadl, A. El-Shorbagi, Z. Hozein and A. Sarhan, Al-Azhar First International Conference on Recent Advances in Pharmaceutical Technology and Biological Sciences, Cairo - Egypt, December 19-21(1995), p. 95.
25. Synthesis, Hydrolysis Kinetics, Lipophilicity, and Biological Activity of N4-(3-Alkoxy and Benzyloxycarbonylpropionyl)-Ara-C Prodrugs, T.A.Fadl, T.Hasegawa, A.F.Youssef, H.H.Farag, F.A.Omar and T.Kawaguchi, World congress of Pharmacy and Pharmaceutical Sciences "FIP'93", Tokyo, Japan, September 5-10(1993), Abstract No. S098.
26. 1HNMR and chelating properties of 1,5-dimethyl-N-substituted -1H- pyrazole-3-carboxamides and 1,3-dimethyl-N-substituted-1H- pyrazole-5-carboxamides,T.A. Fadl, A. F. Youssef, A. N. Ahmed, 3rd IBN SINA Symposium on Heterocyclic Chemistry, Aswan, Egypt, January 28-31(1991), p. 126